Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 22,751 | 20,041 | 19,596 | 17,519 | 18,406 |
| Cost of Goods | 8,246 | 7,867 | 7,769 | 7,169 | 6,960 |
| Gross Profit | 14,505 | 12,174 | 11,827 | 10,350 | 11,446 |
| Operating Expenses | 20,668 | 21,996 | 18,640 | 16,887 | 19,015 |
| Operating Income | -5,917 | -8,955 | -6,044 | -6,368 | -6,609 |
| Interest Expense | 481 | 448 | 2,518 | 815 | 808 |
| Other Income | 150 | 226 | 123 | 134 | 119 |
| Pre-tax Income | -6,248 | -9,177 | -8,439 | -7,049 | -7,298 |
| Net Income Continuous | -6,248 | -9,177 | -8,439 | -7,049 | -7,298 |
| Net Income | $-6,248 | $-9,177 | $-8,439 | $-7,049 | $-7,298 |
| EPS Basic Total Ops | -0.18 | -0.27 | -0.24 | -0.21 | -0.22 |
| EPS Basic Continuous Ops | -0.18 | -0.27 | -0.25 | -0.21 | -0.22 |
| EPS Diluted Total Ops | -0.18 | -0.27 | -0.24 | -0.21 | -0.22 |
| EPS Diluted Continuous Ops | -0.18 | -0.27 | -0.25 | -0.21 | -0.22 |
| EBITDA(a) | $-4,920 | $-7,967 | $-4,649 | $-5,349 | $-5,638 |